423
Views
12
CrossRef citations to date
0
Altmetric
Research Article

MicroRNA-based therapy: a new dimension in epilepsy treatment

, &
Pages 617-622 | Received 06 Jan 2013, Accepted 21 Mar 2013, Published online: 09 May 2013

References

  • Fisher RS, van Emde BW, Blume W, Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005;46:470–2.
  • Baker GA, Jacoby A, Buck D, Quality of life of people with epilepsy: a European Study. Epilepsia 1997;38:353–62.
  • Chang BS, Lowenstein DH. Epilepsy. N Engl J Med 2003;349:1257–66.
  • Cavanna AE, Cavanna S, Cavanna A. Epileptic seizures and sprit possession in Haitian culture: a report of four cases and review of the literature. Epilepsy Behav 2010;19:89–91.
  • Duncan JS, Sander JW, Sisodiya SM, Walker MC. Adult epilepsy. Lancet 2006;367:1087–100.
  • WHO Media Center. Epilepsy [Internet]. Available from: http://www.who.int/mediacentre/factsheets/fs999/en [last accessed 22 Nov 2012].
  • Browne TR, Holmes GL. Epilepsy: Definitions and Background. In: A hand book of epilepsy. 4th ed. New York: Lippincott Williams and Wilkins; 2008: 2–3.
  • Lhatoo SD, Johnson AL, Goodridge DM, Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort. Ann Neurol 2001;49:336–44.
  • Gaitatzis A, Johnson AL, Chadwick DW, Life expectancy in people with newly diagnosed epilepsy. Brain 2004;127:2427–32.
  • Hitiris N, Mohanraj R, Norrie J, Brodie MJ. Mortality in epilepsy. Epilepsy Behav 2007;10:363–76.
  • Kotsopoulos IA, van Merode T, Kessels FG, Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures. Epilepsia 2002;43:1402–9.
  • Bell GS, Sander JW. CPD-education and self-assessment the epidemiology of epilepsy: the size of the problem. Seizure 2001;10:306–16.
  • Carpio A, Hauser WA. Epilepsy in the developing world. Curr Neurol Neurosci Rep 2009;9:319–26.
  • Heaney DC, MacDonald BK, Everitt A, Socioeconomic variation in incidence of epilepsy: prospective community based study in south east England. BMJ 2002;325:1013–6.
  • Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281–97.
  • Chen K, Rajewsky N. The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet 2007;8:93–103.
  • Pillai RS, Bhattacharyya SN, Filipowicz W. Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol 2007;17:118–26.
  • Bentwich I, Avniel A, Karov Y, Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 2005;37:766–70.
  • Esquela KA, Slack FJ. OncoMirs –microRNAs with a role in cancer. Nat Rev Cancer 2006;6:259–69.
  • Lee Y, Kim M, Han J, MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004;23:4051–60.
  • Provost P, Dishart D, Doucet J, Ribonuclease activity and RNA binding of recombinant human dicer. EMBO J 2002;21:5864–74.
  • Lee Y. Ahn C, Choi H, The nuclear RNase III Drosha initiates microRNA processing. Nature 2003;425:415–9.
  • Khvorova A, Reynolds A, Jayasena SD. Functional siRNAs and miRNAs exhibit strand bias. Cell 2003;115:209–16.
  • Schwarz DS, Hutvagner G, Du T, Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003; 115:199–208.
  • Sander JW. The use of antiepileptic drugs-principles and practice. Epilepsia 2004;45:28–34.
  • Cascino GD. Epilepsy: contemporary perspectives on evaluation and treatment. Mayo Clin Proc 1994;69:1199–211.
  • Engel J, Jr. Surgery for seizures. N Engl J Med 1996;334:647–52.
  • Picot MC, Neveu D, Kahane P, Cost-effectiveness of epilepsy surgery in a cohort of patients with medically intractable partial epilepsy –preliminary results. Rev Neurol (Paris) 2004;160:(5)S354–67.
  • Wiebe S, Matijevic S, Eliasziw M, Derry PA. Clinically important change in quality of life in epilepsy. J Neurol Neurosurg Psychiatry 2002;73:116–20.
  • McIntosh AM, Kalnins RM, Mitchell LA, Temporal lobectomy: long-term seizure outcome, late recurrence and risks for seizure recurrence. Brain 2004;127:2018–30.
  • Lhatoo SD, Solomon JK, McEvoy AW, A prospective study of the requirement for and the provision of epilepsy surgery in the United Kingdom. Epilepsia 2003;44:673–6.
  • Pichardo-Casas I, Goff LA, Swerdel MR, Expression profiling of synaptic microRNAs from the adult rat brain identifies regional differences and seizure-induced dynamic modulation. Brain Res 2012;1436:20–33.
  • McKiernan RC, Jimenez-Mateos EM, Bray I, Reduced mature microRNA levels in association with dicer loss in human temporal lobe epilepsy with hippocampal sclerosis. PLoS One 2012;7:e35921.
  • Hu K, Zhang C, Long L, Expression profile of microRNAs in rat hippocampus following lithium-pilocarpine-induced status epilepticus. Neurosci Lett 2011;488:252–7.
  • Hu K, Xie YY, Zhang C, MicroRNA expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-34a-targeted neuroprotection against hippocampal neurone cell apoptosis post-status epilepticus. BMC Neurosci 2012;13:115.
  • Jimenez-Mateos EM, Bray I, Sanz-Rodriguez A, miRNA expression profile after status epilepticus and hippocampal neuroprotection by targeting miR-132. Am J Pathol 2011;179:2519–32.
  • Kan AA, van Erp S, Derijck AA, Genome-wide microRNA profiling of human temporal lobe epilepsy identifies modulators of the immune response. Cell Mol Life Sci 2012;69:3127–45.
  • Sano T, Reynolds JP, Jimenez-Mateos EM, MicroRNA-34a upregulation during seizure-induced neuronal death. Cell Death Dis 2012;3:e287.
  • Nudelman AS, DiRocco DP, Lambert TJ, Neuronal activity rapidly induces transcription of the CREB-regulated microRNA-132, in vivo. Hippocampus 2010;20:492–8.
  • Iyer A, Zurolo E, Prabowo A, MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response. PLoS One 2012;7:e44789.
  • Aronica E, Fluiter K, Iyer A, Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur J Neurosci 2010;31:1100–7.
  • Omran A, Peng J, Zhang C, Interleukin-1β and microRNA-146a in an immature rat model and children with mesial temporal lobe epilepsy. Epilepsia 2012;53:1215–24.
  • Jimenez-Mateos EM, Engel T, Merino-Serrais P, Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects. Nat Med 2012;18:1087–94.
  • Liu DZ, Tian Y, Ander BP, Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J Cereb Blood Flow Metab 2010;30:92–101.
  • Song YJ, Tian XB, Zhang S, Temporal lobe epilepsy induces differential expression of hippocampal miRNAs including let-7e and miR-23a/b. Brain Res 2011;1387:134–40.
  • Risbud RM, Lee C, Porter BE. Neurotrophin-3 mRNA a putative target of miR21 following status epilepticus. Brain Res 2011;1424:53–59.
  • Boison D. Engineered adenosine-releasing cells for epilepsy therapy: human mesenchymal stem cells and human embryonic stem cells. Neurotherapeutics 2009;6:278–83.
  • Bjorklund O, Shang MM, Tonazzini I, Adenosine A(1) and A(3) receptors protect astrocytes from hypoxic damage. Eur J Pharmacol 2008;596:6–13.
  • Boison D. Adenosine as a neuromodulator in neurological diseases. Curr Opin Pharmacol 2008;8:2–7.
  • Park J, Gupta RS. Adenosine kinase and ribokinase –the RK family of proteins. Cell Mol Life Sci 2008; 65:2875–96.
  • Studer FE, Fedele DE, Marowsky A, Shift of adenosine kinase expression from neurons to astrocytes during postnatal development suggests dual functionality of the enzyme. Neuroscience 2006;142:125–37.
  • Ren G, Boison D. Engineering human mesenchymal stem cells to release adenosine using miRNA technology. Methods Mol Biol 2010;650:225–40.
  • Aronica E, Boer K, van Vliet EA, Complement activation in experimental and human temporal lobe epilepsy. Neurobiol Dis 2007;26:497–511.
  • Aronica E, Gorter J. Gene expression profile in temporal lobe epilepsy. Neuroscientist 2007;13:100–8.
  • van Gassen KL, de Wit M, Koerkamp MJ, Possible role of the innate immunity in temporal lobe epilepsy. Epilepsia 2008;49:1055–65.
  • Jarvela JT, Lopez-Picon FR, Plysjuk A, Temporal profiles of age-dependent changes in cytokine mRNA expression and glial cell activation after status epilepticus in postnatal rat hippocampus. J Neuroinflammation 2011;8:29.
  • Silveira G, de Oliveira AC, Teixeira AL. Insights into inflammation and epilepsy from the basic and clinical sciences. J Clin Neurosci 2012;19:1071–5.
  • Vezzani A, Friedman A, Dingledine RJ. The role of inflammation in epileptogenesis. Neuropharmacology 2013;69:16–24.
  • Blasius AL, Beutler B. Intracellular toll-like receptors. Immunity 2010;32:305–15.
  • Viviani B, Bartesaghi S, Gardoni F, Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 2003;23:8692–700.
  • Kan AA, van der Hel WS, Kolk SM, Prolonged increase in rat hippocampal chemokine signalling after status epilepticus. J Neuroimmunol 2012;245:15–22.
  • Pearson G, Robinson F, Beers Gibson T, Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 2001;22:153–83.
  • Boison D. Inhibitory RNA in epilepsy: research tool and therapeutic perspectives. Epilepsia 2010;51:1659–68.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.